Source: Blackline Safety Corp.
Market Herald logo

Find out more about this capital raise

Be the first with the news that moves the market
  • Blackline Safety Corp. (BLN) has upsized its non-brokered private placement to $13 million
  • The private placement will be completed concurrently with an $8 million bought deal
  • The offering and concurrent private placement are scheduled to close by August 31
  • Blackline Safety Corp is a connected safety monitoring technology company
  • Blackline Safety Corp. (BLN) is down 1.33 per cent and is trading at $2.22 per share as of 3:25 p.m. ET

Blackline Safety Corp. (BLN) has upsized its previously announced non-brokered private placement to $13 million.

The offering and concurrent private placement are scheduled to close by August 31.

Blackline has granted the underwriters an over-allotment option to purchase up to an additional 15 per cent of common shares equal to the offering price, exercisable at any time up to 30 days after closing.

The terms of the offering remain unchanged.

Blackline Safety is a technology company enabling companies to drive towards zero safety incidents and improved operational performance.

Blackline provides wearable devices, personal and area gas monitoring, cloud-connected software, and data analytics to meet demanding safety challenges and enhance overall productivity for organizations with coverage in more than 100 countries.

Blackline Safety Corp. (BLN) is down 1.33 per cent and is trading at $2.22 per share as of 3:25 p.m. ET.


More From The Market Herald
VitalHub

" VitalHub (TSX:VHI) announces multi year contract with NHS Mid and South Essex ICB

VitalHub (VHI) announced a multi-year licensing contract with NHS Mid and South Essex Integrated Care Board (Essex).

" SpotLite360 (CSE:LITE) closes private placement

SpotLite360 IOT Solutions (LITE) has closed a non-brokered private placement for gross proceeds of $350,000.

" Tenet (CSE:PKK) announces short-form prospectus public offering

Tenet Fintech Group (PKK) has obtained a receipt for a preliminary short-form prospectus from the securities regulatory authority in the province of Ontario.

" No pain, no blood: BETTER Type 2 diabetes testing is coming to market

Over the past two years, reporting on the Covid-19 pandemic has dominated media airwaves.